• 1
    Dunlap, N. E., Benjamin, W. H. Jr., McCall, R. D. Jr., Tilden, A. B. and Briles, D. E., A ‘safe-site’ for Salmonella typhimurium is within splenic cells during the early phase of infection in mice. Microb. Pathog. 1991. 10: 297310.
  • 2
    Yrlid, U., Svensson, M., Hakansson, A., Chambers, B. J., Ljunggren, H. G. and Wick, M. J., In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect. Immun. 2001. 69: 57265735.
  • 3
    Mastroeni, P., Immunity to systemic Salmonella infections. Curr. Mol. Med. 2002. 2: 393406.
  • 4
    Makino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K. and Tochino, Y., Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980. 29: 113.
  • 5
    Cooke, A., Tonks, P., Jones, F. M., O'Shea, H., Hutchings, P., Fulford, A. J. and Dunne, D. W., Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999. 21: 169176.
  • 6
    Oldstone, M. B., Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988. 239: 500502.
  • 7
    Baxter, A. G., Horsfall, A. C., Healey, D., Ozegbe, P., Day, S., Williams, D. G. and Cooke, A., Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 1994. 83: 227231.
  • 8
    Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T., Haba, T., Scherer, D. C., Wei, J. et al., The natural killer T cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 10521056.
  • 9
    Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 10571062.
  • 10
    Qin, H. Y., Sadelain, M. W., Hitchon, C., Lauzon, J. and Singh, B., Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 1993. 150: 20722080.
  • 11
    Zaccone, P., Fehervari, Z., Jones, F. M., Sidobre, S., Kronenberg, M., Dunne, D. W. and Cooke, A., Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 2003. 33: 14391449.
  • 12
    Esteban, L. M., Tsoutsman, T., Jordan, M. A., Roach, D., Poulton, L. D., Brooks, A., Naidenko, O. V., Sidobre, S., Godfrey, D. I. and Baxter, A. G., Genetic control of NKT cell numbers maps to major diabetes and lupus Loci. J. Immunol. 2003. 171: 28732878.
  • 13
    Kukreja, A., Costi, G., Marker, J., Zhang, C. H., Sinha, S., Sun, Z. and Maclaren, N., NKT cell defects in NOD mice suggest therapeutic opportunities. J. Autoimmun. 2002. 19: 117128.
  • 14
    Godfrey, D. I., Kinder, S. J., Silvera, P. and Baxter, A. G., Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR-CD8- thymocytes. J. Autoimmun. 1997. 10: 279285.
  • 15
    Baxter, A. G., Kinder, S. J., Hammond, K. J., Scollay, R. and Godfrey, D. I., Association between alphabetaTCR+CD4CD8 T cell deficiency and IDDM in NOD/Lt mice. Diabetes 1997. 46: 572582.
  • 16
    Naumov, Y. N., Bahjat, K. S., Gausling, R., Abraham, R., Exley, M. A., Koezuka, Y., Balk, S. B., Strominger, J. L., Clare-Salzer, M. and Wilson, S. B., Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 2001. 98: 1383813843.
  • 17
    Mittrucker, H. W., Kohler, A. and Kaufmann, S. H., Characterization of the murine T-lymphocyte response to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 2002. 70: 199203.
  • 18
    Debray-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, I., Bedossa, P. and Bach, J. F., Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J. Autoimmun. 1991. 4: 237248.
  • 19
    Sobel, D. O. and Newsome, J., Gamma interferon prevents diabetes in the BB rat. Clin. Diagn. Lab. Immunol. 1997. 4: 764768.
  • 20
    Sobel, D. O., Han, J., Williams, J., Yoon, J. W., Jun, H. S. and Ahvazi, B., Gamma interferon paradoxically inhibits the development of diabetes in the NOD mouse. J. Autoimmun. 2002. 19: 129137.
  • 21
    Nicoletti, F., Zaccone, P., Di Marco, R., Lunetta, M., Magro, G., Grasso, S., Meroni, P. and Garotta, G., Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody. Endocrinology 1997. 138: 281288.
  • 22
    Serreze, D. V., Chapman, H. D., Post, C. M., Johnson, E. A., Suarez-Pinzon, W. L. and Rabinovitch, A., Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J. Immunol. 2001. 166: 13521359.
  • 23
    Kukreja, A. and Maclaren, N. K., NKT cells and type-1 diabetes and the “hygiene hypothesis” to explain the rising incidence rates. Diabetes Technol. Ther. 2002. 4: 323333.
  • 24
    Eberl, G. and MacDonald, H. R., Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 1998. 9: 345353.
  • 25
    Martinez del Hoyo, G., Martin, P., Arias, C. F., Marin, A. R. and Ardavin, C., CD8alpha+ dendritic cells originate from the CD8alpha dendritic cell subset by a maturation process involving CD8alpha, DEC-205, and CD24 up-regulation. Blood 2002. 99: 9991004.
  • 26
    De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Urbain, J., Leo, O. and Moser, M., Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 1996. 184: 14131424.
  • 27
    Lund, T., O'Reilly, L., Hutchings, P., Kanagawa, O., Simpson, E., Gravely, R., Chandler, P., Dyson, J., Picard, J. K., Edwards, A. et al., Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature 1990. 345: 727729.
  • 28
    Shinomiya, M., Fazle Akbar, S. M., Shinomiya, H. and Onji, M., Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin. Exp. Immunol. 1999. 117: 3843.
  • 29
    Fallarino, F., Vacca, C., Orabona, C., Belladonna, M. L., Bianchi, R., Marshall, B., Keskin, D. B., Mellor, A. L., Fioretti, M. C., Grohmann, U. and Puccetti, P., Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int. Immunol. 2002. 14: 6568.
  • 30
    Grohmann, U., Fallarino, F., Bianchi, R., Orabona, C., Vacca, C., Fioretti, M. C. and Puccetti, P., A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J. Exp. Med. 2003. 198: 153160.
  • 31
    Hoiseth, S. K. and Stocker, B. A., Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981. 291: 238239.
  • 32
    Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. and Kronenberg, M., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741754.